PharmaNews PARO presents: Some very important recommendations for the care of patients with kidney disease in the face of the COVID-19 pandemic! The virus that causes the Coronavirus Disease is called acute severe respiratory syndrome coronavirus 2 (Severe Acute Caul Respiratory Syndrome coronavirus 2, SARS-CoV-2). It can be transmitted from one infected person’s respiratory droplets to the mouth, eyes and/or nose of another person. Currently, there is no officially approved or effective therapeutic treatment against COVID-19. However, the therapeutic potential of different drugs, such as remdesivir, lopinavir/ritonavir, chloroquine, hydroxychloroquine, interferon, and the modification of the IECA/ARA II prescription are being explored.
Researchers explore the impact of COVID-19 on renal disease and offered solutions in three different scenarios: 1. Patients with stage 5 chronic kidney disease (CKD-5) in chronic renal replacement therapy (RRT) 2. Patients who develop acute kidney injury (AKI) 3. Evaluation of potential kidney donors CKD patients on RRT: Hemodialysis, peritoneal dialysis and transplant patients are a high-risk group for the development of complications. The greatest possibility of infection will occur in patients receiving treatment in hemodialysis centers. ●
Patients must receive seasonal flu (Influenza) vaccine
●
Symptomatic and/or confirmed patients with COVID-19 they should not come into direct contact with other susceptible patients
●
Suspect patients should be separated from other patients, in addition to putting a mask on.
●
They must be evaluated in order to defer dialysis to the last shift day of a 14 day quarantine or until confirming the diagnosis.
●
Compliance with hand washing or alcohol application must be ensured before and after contact with each patient.
●
In the case of presenting symptoms suggestive of infection or of known contact with a confirmed case, your immediate supervisor should be informed before the patient goes to the dialysis unit
Patients who have an episode of ARI: ●
Have exclusive hospital areas for infected patients that have the ability to administer dialysis, both at a moderate and intensive level of care
●
In case of not having exclusive hospital areas, each hospital area should: 1) Have an isolated area to dialyze these patients. 2) in case of having two or more hemodialysis stations, the stations must have a distance of at least 1.85 meters
Potential Donors: ●
Health authorities are recommended to postpone any donation of organs, blood, cells and tissues from donors after possible exposure to a confirmed case
●
Donors that are confirmed cases of COVID-19 after the period of symptom seolution should be ruled out.
●
For potential organ donors at risk of being infected, will undergo laboratory tests to rule out whether they have had the presence of the virus.
All credits of scientific information are for the authors of the scientific article creation! Scientific information reference: https://slanh.net/wp-content/uploads/2020/03/SLANH-STALYC-API_Recomendaciones -para-el-manejo-de-pacientes-portadores-de-enfermedad-renal-frente-a-la-epidemia-de -coronavirus-COVID-19.pdf Ilustration: